Translating the concept of peptide labeling with 5-deoxy-5-[18F]fluororibose into preclinical practice: 18F-labeling of Siglec-9 peptide for PET imaging of inflammation

Chem Commun (Camb). 2013 May 7;49(35):3682-3684. doi: 10.1039/c3cc40738a. Epub 2013 Mar 27.

Abstract

Peptide glycosylation with 5-deoxy-5-[(18)F]fluororibose was translated into preclinical settings. The novel (18)F-labeled Siglec-9 peptide was produced using an automated synthesis procedure. The (18)F-labeled Siglec-9 peptide showed favorable binding in the animal model of inflammation in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amine Oxidase (Copper-Containing) / metabolism
  • Animals
  • Antigens, CD / chemistry*
  • Cell Adhesion Molecules / metabolism
  • Inflammation / diagnosis
  • Inflammation / metabolism
  • Peptides / chemistry*
  • Positron-Emission Tomography / methods
  • Rats
  • Ribose / analogs & derivatives
  • Ribose / chemistry
  • Sialic Acid Binding Immunoglobulin-like Lectins / chemistry*

Substances

  • 5-deoxy-5-(18F)fluororibose
  • Antigens, CD
  • Cell Adhesion Molecules
  • Peptides
  • Sialic Acid Binding Immunoglobulin-like Lectins
  • Ribose
  • Amine Oxidase (Copper-Containing)
  • vascular adhesion protein-1, rat